Synergy CHC Corp. (SNYR)
NASDAQ: SNYR · Real-Time Price · USD
2.460
-0.100 (-3.91%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Synergy CHC Revenue
Synergy CHC had revenue of $8.13M in the quarter ending June 30, 2025, with 1.37% growth. This brings the company's revenue in the last twelve months to $33.70M, down -18.71% year-over-year. In the year 2024, Synergy CHC had annual revenue of $34.83M, down -18.57%.
Revenue (ttm)
$33.70M
Revenue Growth
-18.71%
P/S Ratio
0.60
Revenue / Employee
$1,604,908
Employees
21
Market Cap
27.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.83M | -7.94M | -18.57% |
| Dec 31, 2023 | 42.78M | 4.37M | 11.37% |
| Dec 31, 2022 | 38.41M | -1.82M | -4.51% |
| Dec 31, 2020 | 40.23M | 10.87M | 37.02% |
| Dec 31, 2019 | 29.36M | -4.47M | -13.21% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SNYR News
- 5 weeks ago - Synergy CHC Corp. (NASDAQ: SNYR) Partners with AlaBev to Launch FOCUSfactor® Beverages in 5,000+ Retail Outlets Across Alabama - GlobeNewsWire
- 2 months ago - Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering - GlobeNewsWire
- 2 months ago - Synergy CHC Corp. Announces Pricing of $4.375 Million Public Offering - GlobeNewsWire
- 2 months ago - Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability - GlobeNewsWire
- 4 months ago - Synergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Help Drive FOCUSfactor Energy Drink Global Expansion - GlobeNewsWire
- 5 months ago - Synergy CHC Announces New $20 Million Long-Term Credit Facility - GlobeNewsWire
- 6 months ago - Synergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information - GlobeNewsWire
- 1 year ago - U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha